1. Decoding the usefulness of non-coding RNAs as breast cancer markers
    Maria Amorim et al, 2016, J Transl Med CrossRef
  2. Expression Data Analysis for the Identification of Potential Biomarker of Pregnancy Associated Breast Cancer
    Raja Rajeswary Thanmalagan et al, 2016, Pathol. Oncol. Res. CrossRef
  3. Cell cycle arrest and induction of apoptosis by cajanin stilbene acid from Cajanus cajan in breast cancer cells
    Yujie Fu et al, 2015, Phytomedicine CrossRef
  4. Use of the disulfiram/copper complex for breast cancer chemoprevention in MMTV-erbB2 transgenic mice
    YANHUI YANG et al, 2015 CrossRef
  5. Cancer nanotheranostics: Strategies, promises and impediments
    Moumita Roy Chowdhury et al, 2016, Biomedicine & Pharmacotherapy CrossRef
  6. null
    Sepideh Mansouri et al, 2017 CrossRef
  7. 27-hydroxycholesterol: A novel player in molecular carcinogenesis of breast and prostate cancer
    Gurdeep Marwarha et al, 2017, Chemistry and Physics of Lipids CrossRef
  8. Palladium-Catalyzed Ortho-Arylation of Carbamate-Protected Estrogens
    Robin B. Bedford et al, 2016, J. Org. Chem. CrossRef
  9. Cooperative antitumor activities of carnosic acid and Trastuzumab in ERBB2+ breast cancer cells
    Carolina D’Alesio et al, 2017, J Exp Clin Cancer Res CrossRef
  10. Explorative visual analytics on interval-based genomic data and their metadata
    Vahid Jalili et al, 2017, BMC Bioinformatics CrossRef
  11. The role of cystatin A in breast cancer and its functional link with ERα
    Dixcy Jaba Sheeba John Mary et al, 2017, Journal of Genetics and Genomics CrossRef
  12. Current issues with luminal subtype classification in terms of prediction of benefit from endocrine therapy in early breast cancer
    Lutfi Alfarsi et al, 2018, Histopathology CrossRef
  13. A combined approach with gene-wise normalization improves the analysis of RNA-seq data in human breast cancer subtypes
    Xiaohong Li et al, 2018, PLoS ONE CrossRef
  14. Epigenetic Changes of the ESR1 Gene in Breast Tissue of Healthy Women: A Missing Link with Breast Cancer Risk Factors?
    Abdolreza Daraei et al, 2017, Genetic Testing and Molecular Biomarkers CrossRef
  15. Classifying Breast Cancer Subtypes Using Multiple Kernel Learning Based on Omics Data
    Mingxin Tao et al, 2019, Genes CrossRef
  16. Glutathione S ‐transferase omega 1 inhibition activates JNK ‐mediated apoptotic response in breast cancer stem cells
    Kanakaraju Manupati et al, 2019, FEBS J CrossRef
  17. HER2 induced EMT and tumorigenicity in breast epithelial progenitor cells is inhibited by coexpression of EGFR
    S Ingthorsson et al, 2016, Oncogene CrossRef
  18. MiR-195 regulates mitochondrial function by targeting mitofusin-2 in breast cancer cells
    Paresh Kumar Purohit et al, 2019, RNA Biology CrossRef
  19. MicroRNA-195 inhibits proliferation, invasion and metastasis in breast cancer cells by targeting FASN, HMGCR, ACACA and CYP27B1
    Richa Singh et al, 2015, Sci Rep CrossRef
  20. The functional ALDH2 polymorphism is associated with breast cancer risk: A pooled analysis from the Breast Cancer Association Consortium
    Tomotaka Ugai et al, 2019, Mol Genet Genomic Med CrossRef
  21. Association of miR-1266 with Recurrence/Metastasis Potential in Estrogen Receptor Positive Breast Cancer Patients
    Elif Demirdogen Sevinc et al, 2015, Asian Pacific Journal of Cancer Prevention CrossRef
  22. From bench to bedside: What do we know about hormone receptor-positive and human epidermal growth factor receptor 2-positive breast cancer?
    Victoria Shang Wu et al, 2015, The Journal of Steroid Biochemistry and Molecular Biology CrossRef
  23. Human Epidermal Growth Factor Receptor 2 (HER2) Impedes MLK3 Kinase Activity to Support Breast Cancer Cell Survival
    Subhasis Das et al, 2015, J. Biol. Chem. CrossRef
  24. Increased expression of ZNF 703 in breast cancer tissue: An opportunity for RNAi–NSAID combinatorial therapy
    Marzieh Marzbany et al, 2019, Biotechnology and Applied Biochemistry CrossRef
  25. Targeting glycolysis by 3-bromopyruvate improves tamoxifen cytotoxicity of breast cancer cell lines
    Yasmin M. Attia et al, 2015, BMC Cancer CrossRef
  26. Estrogen Receptor Expression Is Associated with DNA Repair Capacity in Breast Cancer
    Jaime Matta et al, 2016, PLoS ONE CrossRef
  27. Predictive and Prognostic Value of Selected MicroRNAs in Luminal Breast Cancer
    Maria Amorim et al, 2019, Front. Genet. CrossRef
  28. Context Specific and Differential Gene Co-expression Networks via Bayesian Biclustering
    Chuan Gao et al, 2016, PLoS Comput Biol CrossRef
  29. Formal modeling and analysis of ER-αassociated Biological Regulatory Network in breast cancer
    Samra Khalid et al, 2016 CrossRef
  30. Design, synthesis, and biological evaluation of novel 1-oxo-1,2,3,4-tetrahydropyrazino[1,2-a]indole-3-carboxamide analogs in MCF-7 and MDA-MB-468 breast cancer cell lines
    Ye Jin Kim et al, 2017, Bioorganic & Medicinal Chemistry Letters CrossRef
  31. High tumor-infiltrating FoxP3 + T cells predict poor survival in estrogen receptor-positive breast cancer: A meta-analysis
    F. Qian et al, 2017, European Journal of Surgical Oncology (EJSO) CrossRef
  32. A One-pot Multicomponent ‘Click’ Approach to the Synthesis of Novel Tamoxifen-triazole Conjugates using Nano Iron Oxide Catalyst and their Preliminary Antiproliferative Activity Studies
    Mohana Rao Katiki et al, 2019, LDDD CrossRef
  33. Evaluation of Tamoxifen and Simvastatin as the Combination Therapy for the Treatment of Hormonal Dependent Breast Cancer cells
    Amel B. Ibrahim et al, 2019, Toxicology Reports CrossRef
  34. Dietary Inflammatory Index and Risk of Breast Cancer Based on Hormone Receptor Status: A Case-Control Study in Korea
    null Lee et al, 2019, Nutrients CrossRef
  35. null
    Anne C. Avery et al, 2020 CrossRef
  36. null
    Qurrat Ul Ain, 2019 CrossRef
  37. Overcoming tamoxifen resistance in oestrogen receptor‐positive breast cancer using the novel thiosemicarbazone anti‐cancer agent, DpC
    Sundus N. Maqbool et al, 2020, Br J Pharmacol CrossRef
  38. Characteristics, behaviour and role of biomarkers in metastatic triple-negative breast cancer
    Yutaro Goto et al, 2020, J Clin Pathol CrossRef
  39. The implication of the SUMOylation pathway in breast cancer pathogenesis and treatment
    Andrea Rabellino et al, 2020, Critical Reviews in Biochemistry and Molecular Biology CrossRef
  40. null
    Nur Fitriana et al, 2020 CrossRef
  41. Transcriptional regulation of mixed lineage kinase 3 by estrogen and its implication in ER-positive breast cancer pathogenesis
    Navin Viswakarma et al, 2017, Oncotarget CrossRef
  42. Genomic regulation of invasion by STAT3 in triple negative breast cancer
    Joy M. McDaniel et al, 2017, Oncotarget CrossRef
  43. Identification of glycerol-3-phosphate dehydrogenase 1 as a tumour suppressor in human breast cancer
    Cefan Zhou et al, 2017, Oncotarget CrossRef
  44. HDAC3–ERα Selectively Regulates TNF-α-Induced Apoptotic Cell Death in MCF-7 Human Breast Cancer Cells via the p53 Signaling Pathway
    Seung-Ho Park et al, 2020, Cells CrossRef
  45. MLL3 Induced by Luteolin Causes Apoptosis in Tamoxifen-Resistant Breast Cancer Cells through H3K4 Monomethylation and Suppression of the PI3K/AKT/mTOR Pathway.
    Han-Tsang Wu et al, 2020, Am J Chin Med CrossRef
  46. MicroRNAs and gene regulation in breast cancer
    Fatma Abdalla et al, 2020, J Biochem Mol Toxicol CrossRef
  47. Abemaciclib, a CDK4 and CDK6 inhibitor for the treatment of metastatic breast cancer
    Miguel Martin et al, 2020, Future Oncology CrossRef
  48. High Parity Predicts Poor Outcomes in Patients With Luminal B-Like (HER2 Negative) Early Breast Cancer: A Prospective Finnish Single-Center Study
    Anniina Jääskeläinen et al, 2020, Front. Oncol. CrossRef
  49. Inhibition of O-GlcNAc transferase activates tumor-suppressor gene expression in tamoxifen-resistant breast cancer cells
    Anna Barkovskaya et al, 2020, Sci Rep CrossRef
  50. Genistin attenuates cellular growth and promotes apoptotic cell death breast cancer cells through modulation of ERalpha signaling pathway
    Sun Tae Hwang et al, 2020, Life Sciences CrossRef
  51. Genome-wide analysis of therapeutic response uncovers molecular pathways governing tamoxifen resistance in ER+ breast cancer
    Sarra M. Rahem et al, 2020, EBioMedicine CrossRef
  52. Current Targets and Bioconjugation Strategies in Photodynamic Diagnosis and Therapy of Cancer
    Salvador Gomez et al, 2020, Molecules CrossRef
  53. An Improved, Assay Platform Agnostic, Absolute Single Sample Breast Cancer Subtype Classifier
    Mi-kyoung Seo et al, 2020, Cancers CrossRef
  54. Luminal A Breast Cancer Co-expression Network: Structural and Functional Alterations
    Diana García-Cortés et al, 2021, Front. Genet. CrossRef
  55. Prediction of severe neutropenia and diarrhoea in breast cancer patients treated with abemaciclib
    Natansh D. Modi et al, 2021, The Breast CrossRef
  56. CBP-JMF: An Improved Joint Matrix Tri-Factorization Method for Characterizing Complex Biological Processes of Diseases
    Bingbo Wang et al, 2021, Front. Genet. CrossRef
  57. Detecting accurate tumor size across imaging modalities in breast cancer
    Olutayo Sogunro et al, 2021, BD CrossRef
  58. CRISPR/Cas9 based genome editing for targeted transcriptional control in triple-negative breast cancer
    Desh Deepak Singh et al, 2021, Computational and Structural Biotechnology Journal CrossRef
  59. Strategic Developments & Future Perspective on Gene Therapy for Breast Cancer: Role of mTOR and Brk/ PTK6 as Molecular Targets.
    Roja Sahu et al, 2020, Curr Gene Ther CrossRef
  60. α-Mangostin Nanoparticles Cytotoxicity and Cell Death Modalities in Breast Cancer Cell Lines
    Yedi Herdiana et al, 2021, Molecules CrossRef
  61. Rapid detection of genetic mutations in individual breast cancer patients by next-generation DNA sequencing
    Suqin Liu et al, 2015, Hum Genomics CrossRef
  62. NRIP1 is activated by C-JUN/C-FOS and activates the expression of PGR, ESR1 and CCND1 in luminal A breast cancer
    Renata Binato et al, 2021, Sci Rep CrossRef
  63. FoxO3a Inhibits Tamoxifen-Resistant Breast Cancer Progression by Inducing Integrin α5 Expression
    Elena Ricci et al, 2022, Cancers CrossRef
  64. The Relationship Between the Tumor Cell Expression of Hypoxic Markers and Survival in Patients With ER-positive Invasive Ductal Breast Cancer
    Suad A.K. Shamis et al, 2022, J Histochem Cytochem. CrossRef
  65. Immunological imbalance, gene polymorphism of biotransformation enzymes, and steroid hormone receptors in tumors in breast cancer patients
    A. N. Glushkov et al, 2022, Med. immunol. CrossRef
  66. null
    Erasmo Orrantia-Borunda et al, 2022 CrossRef
  67. Agonistic Effects of Deinoxanthin on Tamoxifen Antiproliferative Activity on HER2 Positive Breast Cancer: An In vitro Study on MDA-MB-453
    Nihan GÜNAY et al, 2023 CrossRef
  68. Impact of the Cancer Cell Secretome in Driving Breast Cancer Progression
    Syazalina Zahari et al, 2023, Cancers CrossRef